is victoza semaglutide What's the Difference Between Saxenda and Victoza? Diabetes patients now have access

In the STEP-1 trial published in The New England Journal of Medicine in 2021, once-weekly subcutaneous semaglutide at 2.4 mg produced a mean placebo-adjusted body weight reduction of 12.4% at 68 weeks in adults with overweight or obesity (Wilding et al., NEJM, 2021)

Q., & Buettner, G

If your provider recommends something else, ask them to explain why and whether you can try Ozempic if the alternative doesnt work

This half-life permits once-weekly dosing in approved formulations

Among these, ergothioneine stands out as a compound that has been demonstrated to correlate with a reduction in chronic diseases associated with aging and an increase in life expectancy